Effect of German chamomile oil application on alleviating atopic dermatitis-like immune alterations in mice

다국어 초록 (Multilingual Abstract)

Historically, German chamomile (GC) oil has been used for treatment of skin disorders. BALB/c mice were sensitized twice a week with 100 μL of 1% 2,4-dinitrochlorobenzene (DNCB) and challenged twice the following week with 100 μL of 0.2% DNCB for atopic dermatitis induction. Thereafter, 3% GC oil was applied daily (70 μL, 6 times week) on the dorsal skin for 4 weeks. Saline or jojoba oil was used for the control mice. Blood was collected after second DNCB challenge, and at 2 and 4 weeks after initiating oil application. Serum IgE levels were significantly lowered in the GC oil application group at the end of the 4-week application period. The GC oil application for 4 weeks resulted in reduction in serum IgG1 level compared with that after 2-week application. The GC oil application group showed a significantly lower serum histamine level than the control group 2 weeks after oil application. Scratching frequency of the GC oil application group was significantly lower than either control groups. This study is to demonstrate GC oil’s immunoregulatory potential for alleviating atopic dermatitis through influencing of Th2 cell activation.

참고문헌 (Reference)

1 이승혜, "마우스에서 2,4-Dinitrochlorobenzene을 이용한 아토피성 피부염 발현 관련면역지표치 분석" 한국독성학회 22 (22): 357-364, 2006

2 Fiorentino DF, "Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones" 170 : 2081-2095, 1989

3 Hartman D, "Two US practitioners’ experience of using essential oils for wound care" 11 : 317-320, 2002

4 Akihisa T, "Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects" 43 : 1255-1260, 1996

5 Standen MD, "The roles of essential oils in the modulation of immune function and inflammation: survey of aromatherapy educators" 14 : 150-161, 2004

6 Kapp A, "The role of eosinophils in the pathogenesis of atopic dermatitis - eosinophil granule proteins as markers of disease activity" 48 : 1-5, 1993

7 Buckle J, "The role of aromatherapy in nursing care" 36 : 57-72, 2001

8 Sanderson CJ, "The production of lymphokines by primary alloreactive T-cell clones: a co-ordinate analysis of 233 clones in seven lymphokine assays" 56 : 575-584, 1985

9 Carle R, "The medicinal use of Matricaria flos" 2 : 147-153, 1992

10 Tamura T, "The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice" 524 : 149-154, 2005

11 Lawrence BM, "Progress in essential oil" 21 : 55-68, 1996

12 Heo Y, "Posttranscriptional inhibition of interferongamma production by lead" 96 : 92-100, 2007

13 Norris DA, "Mechanisms of action of topical therapies and the rationale for combination therapy" 53 (53): S17-25, 2005

14 Heo Y, "Lead differentially modifies cytokine production in vitro and in vivo" 138 : 149-157, 1996

15 Koblenzer CS, "Itching and the atopic skin" 104 : S109-113, 1999

16 Wahlgren CF, "Itch and atopic dermatitis: an overview" 26 : 770-779, 1999

17 Snapper CM, "Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production" 236 : 944-947, 1987

18 Heo Y, "In vitro model for modulation of helper T cell differentiation and activation" (24) : 18.9.1-18.9.10, 2005

19 Bardana EJ Jr, "Immunoglobulin E- (IgE) and non-IgEmediated reactions in the pathogenesis of atopic eczema/ dermatitis syndrome (AEDS)" 59 (59): 25-29, 2004

20 Matsumoto M, "IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis" 162 : 1056-1063, 1999

21 Kepron MR, "IL-4 induces the specific rearrangement of gamma 1 genes on the expressed and unexpressed chromosomes of lipopolysaccharideactivated normal murine B cells" 143 : 334-339, 1989

22 Takakura M, "Hyperproduction of IFN-γ by CpG oligodeoxynucleotide-induce exacerbation of atopic dermatitis-like skin lesion in some NC/Nga mice" 125 : 1156-1162, 2005

23 Kurt-Jones EA, "Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness" 166 : 1774-1787, 1987

24 Chan LS, "Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis" 117 : 977-983, 2001

25 Simon D, "Eosinophils and atopic dermatitis" 59 : 561-570, 2004

26 Heo Y, "Effect of diesel exhaust particles and their components on the allergen-specific IgE and IgG1 response in mice" 159 : 143-158, 2001

27 Lester MR, "Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis" 154 : 6174-6181, 1995

28 Kobayashi Y, "Dietary intake of the flower extracts of German chamomile (Matricaria recutita L.) inhibited compound 48/80-induced itch-scratch responses in mice" 10 : 657-664, 2003

29 Del Rosso J, "Corticosteroids: options in the era of steroid-sparing therapy" 53 (53): S50-58, 2005

30 Duda D, "Can clinically relevant histamine release be accurately diagnosed in anaesthetised patients without plasma histamine measurements? Randomised study with nested sampling aimed to change paradigms" 47 (47): S73-74, 1998

31 Abdel-Hamid KM, "Atopic dermatitis. In The Washington Manual Allergy, Asthma, and Immunology Subspecialty Consult" Lippincott Williams & Wilkins 66-73, 2003

32 Boguniewicz M, "Atopic dermatitis and contact dermatitis. In Manual of Allergy and Immunology" Lippincott Williams & Wilkins 165-186, 2002

33 Cerrato P, "Aromatherapy: Is it for real?" 61 : 51-52, 1998

34 Moss M, "Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults" 113 : 15-38, 2003

35 Kobayashi Y, "Antipruritic effect of the single oral administration of German chamomile flower extract and its combined effect with antiallergic agents in ddY mice" 101 : 308-312, 2005